Common Stock, Shares, Outstanding of AVENUE THERAPEUTICS, INC. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
AVENUE THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • AVENUE THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 3,183,558, a 98% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

AVENUE THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 3,183,558 +1,579,400 +98% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 3,183,558 +1,993,834 +168% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 3,183,603 +2,593,415 +439% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 2,108,670 +1,767,346 +518% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 1,604,158 -7,360,064 -82% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 1,189,724 -6,730,761 -85% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 590,188 -6,237,998 -91% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 341,324 -4,432,517 -93% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 8,964,222 +7,482,783 +505% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 7,920,485 -14,214,299 -64% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 6,828,186 -15,306,598 -69% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 4,773,841 +3,367,882 +240% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 1,481,439 -15,312,254 -91% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 22,134,784 +5,386,716 +32% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 22,134,784 +5,386,716 +32% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 1,405,959 -15,341,844 -92% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 16,793,693 +45,890 +0.27% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 16,748,068 +45,265 +0.27% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 16,748,068 +65,265 +0.39% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 16,747,803 +65,613 +0.39% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q3 2020 16,747,803 +86,448 +0.52% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 16,702,803 +143,056 +0.86% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 16,682,803 +125,681 +0.76% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 16,682,190 +6,014,476 +56% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 16,661,355 +5,998,957 +56% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 16,559,747 +6,005,577 +57% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 16,557,122 +6,005,077 +57% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 10,667,714 +402,631 +3.9% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 10,662,398 +397,224 +3.9% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 10,554,170 +513,162 +5.1% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 10,552,045 +527,640 +5.3% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 10,265,083 +7,007,147 +215% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 10,265,174 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 10,041,008 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 10,024,405 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 3,257,936 31 Dec 2016 10-K 01 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.